Offgrid Energy Labs | $15,000,000 | (Sep 4, 2025)
Boomerang Medical | $20,000,000 | (Sep 4, 2025)
LightTable | $6,000,000 | (Sep 4, 2025)
Certified by Founder
Lodge
Delphia Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/05/2024
- Series A
- $67,000,000
Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.
- Industry Biotechnology Research
- Website https://www.delphiatx.com/
- LinkedIn https://www.linkedin.com/company/delphia-therapeutics/
MeetGeek | $1,864,877 | (Sep 4, 2025)
Aurelius Systems | $10,000,000 | (Sep 4, 2025)
Advisor.com | $9,000,000 | (Sep 4, 2025)
Etherealize | $40,000,000 | (Sep 4, 2025)
MEGA.AI | $2,000,000 | (Sep 4, 2025)
Meroka | $6,000,000 | (Sep 4, 2025)
ModernFi | $30,000,000 | (Sep 4, 2025)
Galvanize | $100,000,000 | (Sep 4, 2025)
MagicDoor | $4,500,000 | (Sep 4, 2025)